SI1746980T1 - Farmacevtska dozirna oblika ki obsega pelete kot tudi postopek za njeno pripravo - Google Patents

Farmacevtska dozirna oblika ki obsega pelete kot tudi postopek za njeno pripravo

Info

Publication number
SI1746980T1
SI1746980T1 SI200531457T SI200531457T SI1746980T1 SI 1746980 T1 SI1746980 T1 SI 1746980T1 SI 200531457 T SI200531457 T SI 200531457T SI 200531457 T SI200531457 T SI 200531457T SI 1746980 T1 SI1746980 T1 SI 1746980T1
Authority
SI
Slovenia
Prior art keywords
manufacturing process
pellets
well
dosage form
pharmaceutical dosage
Prior art date
Application number
SI200531457T
Other languages
English (en)
Inventor
Isabel Anstett-Klein
Marc Schiller
Original Assignee
Nycomed Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Gmbh filed Critical Nycomed Gmbh
Publication of SI1746980T1 publication Critical patent/SI1746980T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
SI200531457T 2004-05-07 2005-05-04 Farmacevtska dozirna oblika ki obsega pelete kot tudi postopek za njeno pripravo SI1746980T1 (sl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04101982 2004-05-07

Publications (1)

Publication Number Publication Date
SI1746980T1 true SI1746980T1 (sl) 2012-03-30

Family

ID=34929072

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200531457T SI1746980T1 (sl) 2004-05-07 2005-05-04 Farmacevtska dozirna oblika ki obsega pelete kot tudi postopek za njeno pripravo

Country Status (15)

Country Link
US (1) US20070231388A1 (sl)
EP (1) EP1746980B1 (sl)
JP (1) JP2007536349A (sl)
AT (1) ATE531361T1 (sl)
AU (1) AU2005239838B2 (sl)
CA (1) CA2565083C (sl)
CY (1) CY1112256T1 (sl)
DK (1) DK1746980T3 (sl)
ES (1) ES2376466T3 (sl)
HR (1) HRP20120049T1 (sl)
PL (1) PL1746980T3 (sl)
PT (1) PT1746980E (sl)
RS (1) RS52233B (sl)
SI (1) SI1746980T1 (sl)
WO (1) WO2005107721A2 (sl)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20050150A1 (es) 2003-05-08 2005-03-22 Altana Pharma Ag Una forma de dosificacion que contiene (s)-pantoprazol como ingrediente activo
CL2004000983A1 (es) 2003-05-08 2005-03-04 Altana Pharma Ag Composicion farmaceutica oral en forma de tableta que comprende a pantoprazol magnetico dihidratado, en donde la forma de tableta esta compuesto por un nucleo, una capa intermedia y una capa exterior; y uso de la composicion farmaceutica en ulceras y
TWI372066B (en) 2003-10-01 2012-09-11 Wyeth Corp Pantoprazole multiparticulate formulations
JP2010523554A (ja) 2007-04-04 2010-07-15 シグモイド・ファーマ・リミテッド タクロリムスの医薬組成物
DK2471518T3 (en) 2009-05-18 2017-12-04 Sigmoid Pharma Ltd COMPOSITION INCLUDING OIL DROPS
WO2012103411A2 (en) 2011-01-28 2012-08-02 Zx Pharma, Llc Controlled-release melatonin composition and related methods
US9532952B2 (en) 2011-01-28 2017-01-03 Physician's Seal, LLC Controlled-release compositions of melatonin combined with sedative and/or analgesic ingredients
US8911780B2 (en) 2011-02-11 2014-12-16 Zx Pharma, Llc Multiparticulate L-menthol formulations and related methods
US8568776B2 (en) 2011-02-11 2013-10-29 Zx Pharma, Llc Multiparticulate L-menthol formulations and related methods
US8808736B2 (en) 2011-02-11 2014-08-19 Zx Pharma, Llc Enteric coated multiparticulate controlled release peppermint oil composition and related methods
GB201212010D0 (en) 2012-07-05 2012-08-22 Sigmoid Pharma Ltd Formulations
WO2014175916A1 (en) * 2013-04-23 2014-10-30 Zx Pharma, Llc Enteric coated multiparticulate composition with proteinaceous subcoat
GB201319791D0 (en) 2013-11-08 2013-12-25 Sigmoid Pharma Ltd Formulations
PL3215127T3 (pl) 2014-11-07 2021-05-17 Sublimity Therapeutics Limited Kompozycje zawierające cyklosporynę
CN104382881A (zh) * 2014-11-20 2015-03-04 哈尔滨圣吉药业股份有限公司 一种甲砜霉素肠溶微丸及其制备方法
EP3288556A4 (en) 2015-04-29 2018-09-19 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
JP7212484B2 (ja) * 2017-09-20 2023-01-25 大原薬品工業株式会社 腸溶性被覆顆粒の耐酸性が改善された圧縮成形製剤の製造方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL75400A (en) * 1984-06-16 1988-10-31 Byk Gulden Lomberg Chem Fab Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
US5433959A (en) 1986-02-13 1995-07-18 Takeda Chemical Industries, Ltd. Stabilized pharmaceutical composition
EP0234485B1 (de) * 1986-02-20 1992-04-01 Hoechst Aktiengesellschaft Substituierte Thienoimidazol-Derivate, Verfahren zu ihrer Herstellung, sie enthaltende pharmazeutische Zubereitungen und ihre Verwendung als Magensäuresekretionshemmer
GB2189699A (en) 1986-04-30 1987-11-04 Haessle Ab Coated acid-labile medicaments
CA1256109A (en) * 1986-09-10 1989-06-20 Franz Rovenszky Process for the preparation of derivatives of 4, 5-dihydrooxazoles
FI90544C (fi) * 1986-11-13 1994-02-25 Eisai Co Ltd Menetelmä lääkeaineina käyttökelpoisten 2-pyridin-2-yyli-metyylitio- ja sulfinyyli-1H-bensimidatsolijohdannaisten valmistamiseksi
IL85472A (en) 1987-03-09 1991-06-30 Procter & Gamble Pharmaceutical compositions for treating gastrointestinal disorders
DE3901151A1 (de) 1989-01-17 1990-07-19 Hoechst Ag Stabile pharmazeutische zubereitungen von thienoimidazol-derivaten und deren orale anwendung als magensaeuresekretionshemmer
YU48263B (sh) 1991-06-17 1997-09-30 Byk Gulden Lomberg Chemische Fabrik Gmbh. Postupak za dobijanje farmaceutskog preparata na bazi pantoprazola
FR2692146B1 (fr) * 1992-06-16 1995-06-02 Ethypharm Sa Compositions stables de microgranules d'omeprazole gastro-protégés et leur procédé d'obtention.
DE4322572A1 (de) 1993-07-07 1995-01-12 Byk Gulden Lomberg Chem Fab Beutelverpackung für flüssige Arzneimittel
ES2094694B1 (es) 1995-02-01 1997-12-16 Esteve Quimica Sa Nueva formulacion farmaceuticamente estable de un compuesto de bencimidazol y su proceso de obtencion.
US5945124A (en) * 1995-07-05 1999-08-31 Byk Gulden Chemische Fabrik Gmbh Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole
GB9710800D0 (en) 1997-05-23 1997-07-23 Cipla Limited Pharmaceutical composition and method of preparing it
US20030138485A1 (en) * 1998-01-14 2003-07-24 Daiichi Pharmaceutical Co., Ltd. Disintegrant
DK173431B1 (da) * 1998-03-20 2000-10-23 Gea Farmaceutisk Fabrik As Farmaceutisk formulering omfattende en 2-[[(2-pyridinyl)methyl]sulfinyl]benzimidazol med anti-ulcusaktivitet samt fremgangs
DE19843413C1 (de) * 1998-08-18 2000-03-30 Byk Gulden Lomberg Chem Fab Neue Salzform von Pantoprazol
ES2244167T3 (es) * 1999-12-16 2005-12-01 Laboratorio Medinfar-Produtos Farmaceuticos, S.A. Nuevas preparaciones farmaceuticas multiunitarias estables que contienen bencimidazoles sustituidos.
US6346269B1 (en) 2000-05-08 2002-02-12 Standard Chem. & Pharm. Co., Ltd. Method for preparing an oral formulation containing acid-sensitive drugs and oral formulation made thereby
TW200410955A (en) * 2002-07-29 2004-07-01 Altana Pharma Ag Novel salt of (S)-PANTOPRAZOLE
PE20050150A1 (es) 2003-05-08 2005-03-22 Altana Pharma Ag Una forma de dosificacion que contiene (s)-pantoprazol como ingrediente activo
CL2004000983A1 (es) 2003-05-08 2005-03-04 Altana Pharma Ag Composicion farmaceutica oral en forma de tableta que comprende a pantoprazol magnetico dihidratado, en donde la forma de tableta esta compuesto por un nucleo, una capa intermedia y una capa exterior; y uso de la composicion farmaceutica en ulceras y

Also Published As

Publication number Publication date
AU2005239838A1 (en) 2005-11-17
PL1746980T3 (pl) 2012-03-30
CY1112256T1 (el) 2015-12-09
HRP20120049T1 (hr) 2012-02-29
JP2007536349A (ja) 2007-12-13
ES2376466T3 (es) 2012-03-14
CA2565083A1 (en) 2005-11-17
US20070231388A1 (en) 2007-10-04
ATE531361T1 (de) 2011-11-15
WO2005107721A3 (en) 2006-07-20
EP1746980A2 (en) 2007-01-31
PT1746980E (pt) 2012-01-25
EP1746980B1 (en) 2011-11-02
WO2005107721A2 (en) 2005-11-17
AU2005239838B2 (en) 2011-08-11
RS52233B (en) 2012-10-31
CA2565083C (en) 2014-07-08
DK1746980T3 (da) 2012-01-30

Similar Documents

Publication Publication Date Title
PL1746980T3 (pl) Farmaceutyczna postać dawkowania zawierająca peletki i sposób jej wytwarzania
EA200702627A1 (ru) Дозированные формы для перорального применения, содержащие прогестерон, и способы их изготовления и использования
GEP20105082B (en) (biphenyl) carboxylic acids and derivatives thereof
WO2005097076A3 (en) Low dose pharmaceutical products
WO2008085765A3 (en) Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
MX2007004987A (es) Nuevas formulaciones de tabletas de liberacion modificada para inhibidores de bomba de protones.
WO2007012019A3 (en) Medicaments containing famotidine and ibuprofen and administration of same
HRP20050546B1 (hr) Priprava sterilnih vodenih suspenzija koja obuhvaä†a usitnjene kristaliniäśne sastojke za inhalaciju
TWI264311B (en) Method for manufacturing a low dose pharmaceutical composition having uniform drug distribution and potency
SG158863A1 (en) Intravenous formulations of pde-5 inhibitors
TNSN07337A1 (en) Pharmaceutical composition comprising an indolylmaleimide derivative
UA116334C2 (uk) Тверді форми дозування бендамустину
UA96622C2 (ru) Твердые лекарственные формы, которые содержат алискирен, изготовленные способом сухого гранулирования
EA200401583A1 (ru) Таблетка лазофоксифена и ее покрытие
WO2008120070A3 (en) 2(hydroxyethyl)trimethylammonium thioctate (choline thioctate) displaying hepatoprotective, hypoammoniemic and detoxic action, a method for its production and a pharmaceutical composition based thereon
MX347135B (es) Composición farmacéutica de sabor enmascarado para administración oral, y proceso para la preparación de la misma.
WO2006060681A3 (en) Pharmaceutical composition containing an anti-nucleating agent
NZ603744A (en) Balsalazide formulations and manufacture and use thereof
MXPA05008403A (es) Uso de acido comestible en formas de dosis solidas farmaceuticas de rapida dispersion.
SI1596841T1 (sl) Terapevtski sistem amoksicilina in klavulanske kisline
WO2004078108A3 (fr) Comprime de fenofibrate et procede de fabrication
ATE344665T1 (de) Verfahren zur herstellung einer einen antiretroviralen proteasehemmer enthaltenden pharmazeutischen zusammensetzung mit verbesserter bioverfügbarkeit
TW200505427A (en) A solid oral dosage form of metformin and glyburide and the method of preparation thereof
GB0224492D0 (en) Pharmaceutical compositions of rapid drug delivery system to carry active ingredients for fast dissolving tablets by mouth administration
CR7117A (es) Metodo para fabricar una composicion farmaceutica de dosis baja que tiene una distribucion y potencia del farmaco uniformes